http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111803442-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
filingDate 2020-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111803442-B
titleOfInvention A kind of stabilizer for improving the bioavailability of monoammonium glycyrrhizinate S liquid dosage form and its application
abstract The invention belongs to the technical field of medicine, and in particular relates to a stabilizer for improving the bioavailability of monoammonium glycyrrhizinate S liquid dosage form and application thereof. The invention provides a stabilizer and promotes its use in liver-protecting health care products or nutritional products In the field of application, the stabilizer provided by the present invention can react in the liquid to generate gas CO 2 , thereby replacing the air in the liquid to make the liquid saturated with CO 2 , reducing dissolved oxygen, and finally improving the stability of monoammonium glycyrrhizinate S the goal of. At the same time, the present invention also applies the above stabilizer to the preparation of a liver protection composition comprising monoammonium glycyrrhizinate S. The active ingredients of the composition are not only safe, non-toxic, and have no side effects, but also have a good liver protection effect.
priorityDate 2020-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45357226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449699780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564

Total number of triples: 38.